๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lupus Nephritis (LN)
Clinical trial register · China

Lupus Nephritis (LN) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Nanjing 4 Hefei 2 Guangzhou 2 Changsha 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5 Nanjing4 Hefei2 Guangzhou2 Changsha2
All 16 locations
Target enrolment
to

Lupus Nephritis (LN) trials in China

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
NCT07719140Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)
Peking Union Medical College Hospital
Phase 4
198
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Changchun, Shanghai
2026-07
Not yet open
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
NCT07593911Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN), Multiple Sclerosis, Myasthenia Gravis (MG)
Beijing GoBroad Hospital
Not applicable
75
Beijing
2026-06
Not yet open
Efficacy and Safety of CD19 CAR-ฮณฮด T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
NCT07535138Membranous Nephropathy, Lupus Nephritis (LN), IgA Nephropathy (IgAN)
Air Force Military Medical University, China
Phase EARLY_PHASE1
15
Xi'an
2026-05-01
Recruiting
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
NCT07340463Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Nanjing University School of Medicine
Phase 2
50
Nanjing
2025-12-08
Recruiting
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT07236762Systemic Lupus Erythematosus, Lupus Nephritis (LN), Sjogren's Syndrome, Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Bengbu
2025-11-24
Recruiting
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
NCT07363460Lupus Nephritis (LN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
105
Nanjing
2025-11-18
Recruiting
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
NCT07123519Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Tianjin
2025-08-13
Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
NCT07038382Membranous Nephropathy, Lupus Nephritis (LN)
Shanghai Henlius Biotech
Phase 2
24
Beijing, Changsha, Guangzhou, Hangzhou, Hefei, Luoyang, Nanchang, Nanjing
2025-08-05
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT07104721Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Systemic Sclerosis (SSc), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Hefei
2025-08-04
Not yet open
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292Lupus Nephritis (LN), ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital
Phase 1/2
12
Shanghai
2025-06-20
Recruiting
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
NCT06943937Lupus Nephritis (LN), Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
36
Beijing
2025-04-16
Recruiting
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
NCT06902844Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Tongji Hospital
Not applicable
6
Wuhan
2025-04-05
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
NCT06585514Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Beijing GoBroad Hospital
Phase 1/2
18
Beijing
2024-10-17
Recruiting
High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
NCT06682507Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University
Observational
5,000
Guangzhou
1996-01-01
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/lupus-nephritis-ln

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Lupus Nephritis (LN).

How many Lupus Nephritis (LN) trials are recruiting in China?

11 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lupus Nephritis (LN)), 14 studies
PhaseStudiesRecruitingShare
Phase 14428.6%
Phase 23321.4%
Not applicable2114.3%
Phase 1/22114.3%
Observational117.1%
Phase 4117.1%
Phase EARLY_PHASE1107.1%

Most active sponsors

Lead sponsors with the most studies (Lupus Nephritis (LN))
Lead sponsorStudiesRecruiting
China Immunotech (Beijing) Biotechnology Co., Ltd.44
Beijing GoBroad Hospital21
Air Force Military Medical University, China10
First Affiliated Hospital, Sun Yat-Sen University11
Haisco Pharmaceutical Group Co., Ltd.11
Nanjing University School of Medicine11
Peking Union Medical College Hospital11
Shanghai Changzheng Hospital10
Shanghai Henlius Biotech11
Tongji Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.